Board of Directors

Tuija Keinonen

PhD, Prof, Chair of the Board of Directors, Chief Regulatory Officer

Chief Regulatory Officer, Tuija Keinonen, has extensive experience in contract research business, its establishment and working with pharma industry. She has been working in CRO industry about 30 years and acted as CEO for 15 years (Medfiles Group) as well as clinical research director, quality director and has led contract manufacturing organization. She has held several positions of trust both in the private and public sector as well as board memberships. Tuija applies her expertise for clinical trials, regulatory affairs and outsourcing strategy and that same expertise is shared in her position of Professor of Practice (Pharmaceutical Translation and Innovation) at the School of Pharmacy (University of Eastern Finland).

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Member of the Board of Directors

Aino Kalervo

MSc, MS, Chief Operating Officer

John Goldfinch

MBA, CRM, US Clinical Lead & CEO - TILT Biotherapeutics LLC

Suvi Sorsa

PhD, VP of Clinical Affairs

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Chad Hellmann

MBA, Capital Strategy - Advisor

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Member of the Board of Directors

Víctor Cervera-Carrascón

PhD, VP of Business Development

Hanna Kirk

MSc, VP of Product Development

Riikka Havunen

PhD, VP of Operations

Arto Linnervuo

Legal Advisor, Member of the Board of Directors

Pekka Mattila

MSc, Member of the Board of Directors

Timo Ahopelto

MSc (Tech), Strategy Advisor, Member of the Board of Directors